1. Ceramide-induced cleavage of GPR64 intracellular domain drives Ewing sarcoma.
- Author
-
Suvarna K, Jayabal P, Ma X, Wang H, Chen Y, Weintraub ST, Han X, Houghton PJ, and Shiio Y
- Subjects
- Humans, Cell Line, Tumor, Sphingomyelin Phosphodiesterase metabolism, Oncogene Proteins, Fusion metabolism, Oncogene Proteins, Fusion genetics, Animals, RNA-Binding Protein EWS metabolism, RNA-Binding Protein EWS genetics, Signal Transduction, Protein Domains, Mice, Sarcoma, Ewing metabolism, Sarcoma, Ewing pathology, Receptors, G-Protein-Coupled metabolism, Ceramides metabolism, Proto-Oncogene Protein c-fli-1 metabolism
- Abstract
Ewing sarcoma is a cancer of bone and soft tissue in children and young adults primarily driven by the EWS-FLI1 fusion oncoprotein, which has been undruggable. Here, we report that Ewing sarcoma depends on secreted sphingomyelin phosphodiesterase 1 (SMPD1), a ceramide-generating enzyme, and ceramide. We find that G-protein-coupled receptor 64 (GPR64)/adhesion G-protein-coupled receptor G2 (ADGRG2) responds to ceramide and mediates critical growth signaling in Ewing sarcoma. We show that ceramide induces the cleavage of the C-terminal intracellular domain of GPR64, which translocates to the nucleus and restrains the protein levels of RIF1 in a manner dependent on SPOP, a substrate adaptor of the Cullin3-RING E3 ubiquitin ligase. We demonstrate that both SMPD1 and GPR64 are transcriptional targets of EWS-FLI1, indicating that SMPD1 and GPR64 are EWS-FLI1-induced cytokine-receptor dependencies. These results reveal the SMPD1-ceramide-GPR64 pathway, which drives Ewing sarcoma growth and is amenable to therapeutic intervention., Competing Interests: Declaration of interests The authors declare no competing interests., (Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF